GAVI Alliance

GAVI Health System Strengthening

Support Evaluation

Dated: November 21, 2008

Request for Proposal Number

RFP-0006-08

Table
of
Contents

I.
 Introduction
to
the
GAVI
Alliance: _______________________________________3
II.
 Background
and
Context
for
this
Consultancy _________________________3
III.
 Study
Objectives: ___________________________________________________________5
IV.
 Scope
of
Work: ______________________________________________________________6
V.
 Approaches
and
methodological
issues: ________________________________7
VI.
 Management
&
Oversight
: ________________________________________________9
VII.
Qualifications:_____________________________________________________________ 10
VIII.
Project
Deliverables_____________________________________________________ 10
IX.
 Pricing
and
Cost
Information: __________________________________________ 11
X.
 Timeline:___________________________________________________________________ 12
XI.
 Contact
Information: _____________________________________________________ 12
XII.
Evaluation
Criteria: ______________________________________________________ 12
XIII.
Proposal
Requirements ________________________________________________ 14
XIV.
Required
Proposal
Format: ____________________________________________ 15





GAVI Alliance

RFP-0006-08 Page 3 of 31

I. Introduction
to
the
GAVI
Alliance:
 The GAVI Alliance was launched in 1999 to increase immunisation coverage and reverse widening global disparities in access to vaccines. Governments in industrialized and developing countries, UNICEF, WHO, the World Bank, non-governmental organizations, foundations, vaccine manufacturers, and public health and research institutions work together as partners in the Alliance to achieve common immunisation goals, in recognition that only through a strong and united effort can much higher levels of support for global immunisation be generated. For more information on the GAVI Alliance and the GAVI Foundation, please consult the website at www.gavialliance.org.

II. Background
and
Context
for
this
Consultancy
 The GAVI Alliance was launched in 1999 to increase immunization coverage and reverse widening global disparities in access to vaccines. Between 2000 and 2005, the GAVI Alliance made significant investments to improve immunization in many GAVI-eligible countries. Countries used GAVI resources to introduce new and under-used vaccines, to strengthen immunization services, and to improve injection safety. Recognizing that achieving immunization coverage is dependent upon strong health systems, the Alliance Board took the first steps to expand GAVI support to health systems in early 2005. It requested that partners develop an investment case to articulate GAVI’s potential contribution to health systems as a means of improving immunization coverage, and propose a way forward to support them. Health system constraints, such as demotivated health workers, inadequate management skills and unpredictable financing in the periphery, impede progress towards improved immunization coverage, health care delivery for mothers and children and other health outcomes and also need to be addressed1. The initial proposal recommended that the HSS window remain open to all eligible countries for the 2006-15 period, with a maximum funding level of US$1.8 billion. This long-term approach would give countries the opportunity to receive predictable financing and to synchronise HSS applications with their multi-year planning cycles. In December 2005, the GAVI Alliance and Fund Boards agreed to invest an initial $500 million in the HSS Window until 2010 to address the wider systems related bottlenecks that may hinder the provision of immunization services. The 2005 Board Decision also included an evaluation of the window at the end of this period. The objective of GAVI HSS is to achieve and sustain increased immunization coverage, through strengthening the capacity of the health system to provide immunization and other health services (with a focus on child and maternal health). Countries are encouraged to use GAVI HSS funding to target the “bottlenecks” or barriers in the health system that impede progress in improving the provision of and demand for immunization and other child and maternal health services. (Additional information on GAVI HSS can be found in Annex 1) A further increase to the GAVI HSS window of $300 million was approved by the GAVI Boards in February 2008. As of June 2008, nearly $500 million has been committed to countries and $164 million has been

1 Highlighted in a 2004 study, commissioned by GAVI ALLIANCEand led by Norad, into system barriers to increasing immunization coverage

GAVI Alliance

RFP-0006-08 Page 4 of 31

disbursed.2 Much of the coordination of the HSS investment is through the Alliance partners, while at the global level an HSS task team3 provides oversight of the HSS work plan.

The 2005 investment case planned for two independent evaluations of the HSS window: • An evaluation in 2009, which will allow lessons to be learnt from the first two years of implementation.

(The first HSS money was disbursed in mid 2007.) • By the 2012 evaluation, the impact of health systems strengthening activities funded by GAVI on

immunization coverage (and other health goals) can be assessed. Since the beginning of GAVI HSS, there have been a few assessments of progress and current status. WHO and UNICEF (along with other partners) conducted a review of GAVI HSS proposals in 2007 which found that there was increasing stakeholder participation in the design process; proposals were well-aligned with national plans; and, countries were proposing to tackle both upstream and downstream bottlenecks to better immunization outcomes. The review found that demand-side strategies and activities related to financing of services were often overlooked in proposals. In 2008, the World Bank conducted an assessment of the monitoring frameworks contained in the proposals and an analysis of budgets. Many gaps were found in the monitoring frameworks, with some countries not having baseline values for the core indicators. The relationship between optional indicators selected and the activities being supported with GAVIs are unclear. The budget analysis showed that 45% of GAVI financing was aimed at procurement of equipment, vehicles, computers, and cold chain equipment, as well as construction of buildings; and 10% of resources were for salary incentives. These two categories raise some concerns about long-term sustainability of the interventions. The HSS IRC also provides summaries at the end of each round of deliberations the lessons learned and recommendations for future rounds that will provide valuable information for the evaluation team. In August 2008, the HSS Tracking Study was commissioned. The objective of the Tracking Study is to improve the quality of design, programming and implementation of GAVI HSS resources. In addition, the study aims to develop responsibility and ownership over monitoring of GAVI HSS at country level to promote integration into ongoing processes. Finally, the study will establish a network of countries implementing HSS to facilitate cross-country learning, problem solving, and capacity building. The Tracking Study will be completed by November 2009 and be conducted in three phases. The first phase will be completed by the end of January 2009, and will result in a Synthesis Report based on initial country visits to Ethiopia, DR Congo, Vietnam, Nepal, Kyrgyz Republic, and Zambia. The second phase will be completed by September 2009 when the six country case studies will be finalized. The Tracking Study results will be vitally important as inputs into the Evaluation of the HSS Window as it will provide in-depth information about processes and results in selected countries. The potential overlap in timing between these two activities will pose a challenge which will need to be overcome through continuous exchange of information between the two teams facilitated by the Secretariat and relevant governing body. At the country level, GAVI HSS support is only one source of financing for health systems. National governments, multilateral and bilateral donors, and other global partnerships, such as the GFATM and PEPFAR, are financially and technically supporting health system strengthening. The IHP+ is an opportunity 2 Based on figures provided by the GAVI Secretariat 9/2008. 3 This includes representatives from WHO, Unicef, World Bank, DFID, USAID, NORAD, Bill and Melinda gates Foundation, civil society, developing country representatives and CDC

GAVI Alliance

RFP-0006-08 Page 5 of 31

for GAVI HSS to better align and harmonize its processes with country planning, budgeting, procurement, and monitoring, systems GAVI HSS contributions need to be evaluated and assessed within this context.

III. Study
Objectives:
 Given the level of investment in GAVI HSS so far, and the role of partners in supporting these investments so far, it is important to take stock of what has been accomplished to date, in order to determine the future directions of GAVI Alliance investments in HSS. The emphasis of this evaluation will be on assessing country progress, experiences, and outcomes so as to inform Board decisions on future HSS support. There are five main objectives and areas of evaluation:

1. What has been the experience at country level with GAVI HSS in terms of each of the following: design, implementation, monitoring, integration (harmonization and alignment), management, and outputs/outcomes?

2. What have been the main strengths of GAVI HSS at the country level, and what are specific areas that require further improvement?

3. How has GAVI HSS been supported at regional and global levels—what are the strengths of these processes and which areas require further improvement? 4

4. What has been the value-added of funding HSS through GAVI as compared to other ways of funding HSS?

5. What needs to be done, and by when, at country, regional, and global levels to prepare for a more in-depth evaluation of impact of GAVI HSS in 2012?

The expectation for the 2009 Evaluation of the GAVI HSS Window is to determine to what extent operations at country level and support from global and regional levels, as well as trends in health systems and immunization are heading in the right (positive) direction.

The time frame to be assessed in the Evaluation of the GAVI HSS Window covers the period from the Board Decision in December 2005 until December 2008 (including countries approved for support by the IRC in October 2008).

The timing of the GAVI HSS Evaluation in 2009 means that only a handful of countries will have received HSS funding for three years or more (Annex 2). This is a relatively short time frame in which to see major changes in health systems and changes in the required indicators for GAVI HSS which are immunization-specific. There will also be the challenge of attributing GAVI-specific investments in health systems to changes, as GAVI investments are generally small relative to other health systems investments, these investments may be pooled with other resources, and the time frame is short. However, the extent to which the successful bidder can evaluate outputs and outcomes will not be pre-determined and will be based on the data and information that can be collected and analyzed.

4 Processes include the Regional Working Groups, Monitoring IRC, HSS IRC, HSS Task Team, GAVI Secretariat country visits and communications; disbursement processes; the HSS Guidelines, Application and Updates; and pre-review processes.

GAVI Alliance

RFP-0006-08 Page 6 of 31

The Independent Evaluation will provide recommendations to the GAVI Board on whether the HSS window should be maintained, for how long, and in what capacity. As a secondary outcome, the evaluation will provide recommendations on how HSS support at country, regional, and global levels should be strengthened? 


IV. Scope
of
Work:
 Based on the preliminary data collected, the successful bidder will address the objectives of the evaluation stated above by focusing primarily on country level activities and outcomes (80%), with the balance on regional and global processes and outputs to the extent possible. 1. Based on a review of country proposals and implementation experience:

a) Evaluate the extent to which activities contained in the HSS proposals are being implemented, and identify critical contextual factors that are likely to influence both the design and implementation of HSS interventions financed by GAVI.

b) Evaluate the extent to which GAVI HSS has adhered to each of the initial principles of: country driven; aligned; harmonized; predictable; inclusive and collaborative; catalytic; results-oriented; sustainability conscious. Determine the extent to which there are any meaningful variations and trends and successful models by size of the award, type of governance and health financing arrangements (i.e.,. within IHP+ countries, those with SWAps, and those with pooled financing mechanisms, fragile states, those with strong or weak HSCCs and/or ICCs, etc.).

c) Assess the quality and completeness of country-level monitoring frameworks for GAVI HSS, specifically in terms of the ability to measure changes in the indicators contained in approved HSS proposals, and how GAVI HSS monitoring fits into country level monitoring frameworks. 5

d) In light of findings, assess if current conceptual frameworks on how GAVI HSS financing of activities links to changes in immunization outputs/outcomes are sufficiently robust to assess correlation between GAVI HSS support and changes in immunization coverage and U5 mortality.

e) Prepare and analyze quantitative information on the GAVI HSS countries, including: • an assessment of any initial outcomes of GAVI HSS funding across countries for the three

required indicators (DTP3 coverage, % of districts with DTP3 coverage > 80%, and U5 mortality), if any. Provide additional assessment of all optional outcomes (up to 3 permitted) and any process indicators (up to six permitted) that countries have selected in their proposal for tracking HSS implementation. Provide a brief justification and rationale of how any correlation and any causation between HSS funding and initial outcomes was made.

• A database of baseline health systems indicators (e.g., HMN indicators) for each country approved for GAVI HSS support.

• Information and analysis of disbursement rates and timing of financing from global level (GAVI) to countries, and within countries to implementation of activities.

2. Based on a review of regional and global support mechanisms, including the Regional Working Groups (RWGs), the HSS Task Team, GAVI Secretariat country visits, support and communications; the HSS Independent Review Committee (IRC) and Monitoring IRC; pre-review processes; disbursement processes; and the Guidelines, Application and Updates for HSS:

5 Requirements for indicators changed between Round 1 and subsequent rounds and the evaluation team will need to take this into consideration in the analysis.

GAVI Alliance

RFP-0006-08 Page 7 of 31

a. Create an inventory and timeline of HSS support activities conducted and materials produced. b. Describe strengths and weaknesses of key GAVI HSS processes, and make a set of

recommendations on how the to improve each of those GAVI processes

3. Based on a review of country experiences, outcomes, and regional and global processes:

a) Using data from country studies, develop a logical framework to show how to best evaluate in 2012 whether or not HSS investments: a) correlate with, and b) influence, GAVI HSS indicators (i.e. immunization coverage rates and U5 mortality rates) from HSS activities to processes to outputs/outcomes/impacts.6

b) Based on point 3-a), provide recommendations for the TOR of the GAVI HSS evaluation in

2012, including proposed objectives, scope, evaluation questions; data and information that need to be collected (e.g. identify national HMIS gaps to address, in order to facilitate evaluation of GAVI HSS funding on health outcomes), as well as the systems that need to be put in place between 2009 and 2012 at country, regional, and global levels. Include a timeline for implementing the TOR for the 2012 evaluation

c) Make a recommendation as to what global, regional and national structures and mechanisms need to be in place to support the continuation of the HSS window above the current $800 million limit. Set out specific areas to assess in 2012 that would indicate if changes proposed by the 2009 evaluation lead to expected improvements in process, outcome or impact of the HSS investment

V. Approaches
and
methodological
issues:


1) Illustrative
Questions

 Annex 3 contains a list of illustrative questions to be addressed in the GAVI HSS Evaluation around the topic areas of design, implementation, monitoring, integration/harmonization/alignment, management, and general (for countries), and questions related to assessment of global and regional level processes. Each bidder’s proposal should prioritize, and indicate how questions under each topic area will be addressed, including methods and country selection. A mix of in-depth country work supplemented by a lighter touch assessment may be necessary. Because of the variation in the size of awards and length of time that countries have had HSS resources to implement activities, each bidder should indicate the criteria by which countries have been selected for country-specific evaluation work. Because of the size and timing of GAVI HSS grants, a “one size fits all” design to sampling countries may not make sense.

2) Suggested
methodology
 The Evaluation Team will be expected to conduct state-of-the art evaluation using a mix of quantitative and qualitative techniques. 7 The methodologies proposed should clearly describe how they will be used to

6 This would be one framework for the sum of activities and strategies to be financed by GAVI HSS based on proposals approved through November 1, 2008. 7 See Annex 4 for relevant methodological references

GAVI Alliance

RFP-0006-08 Page 8 of 31

address the scope of work and the illustrative evaluation questions, with a clear rationale and attention to minimizing potential sources of bias and maintaining independence of the Evaluation. The 2009 evaluation will be geared towards the collection and analysis of information contributing to an appreciation of changes over time, in order to strengthen baseline information for the 2012 Evaluation of GAVI HSS.

1 Desk review of relevant documents The GAVI Secretariat will provide the Evaluation Team with a basic package of information and background documents, such as those identified in Annex 4. While excellent knowledge of health systems and techniques for evaluating health systems are important qualifications of the successful bidder, the evaluation exercise will include a desk review of relevant GAVI HSS documentation to quickly advance the assessment. The desk review should form the basis for developing any structured interviews with key information and stakeholders at country, regional, and global levels, and identify areas where additional information needs to be collected. Secondary information should be reviewed at all levels (global, regional, and country level) and include, but are not limited to information on the GAVI Alliance website such as Board documents, presentations, and decisions; GAVI HSS policies; HSS proposals; Annual Funding Requests from countries; Annual Progress Reports, IRC reports and presentations; HSS Task Team reports, meeting minutes, and products; Documentation from country cluster officers; regional and country-level policy documents and strategic frameworks; and country-level Health Sector Coordinating Committee or Inter-Agency Coordinating Committee meeting minutes.

2 Methods for country level assessments Methods for the in-depth country analysis must be both qualitative (through structured interviews) and quantitative (analysis of indicator data and reports). These approaches should include interviews with key stakeholders at national and sub-national levels, including Ministry of Health (MoH) and other line ministry staff, district health officers and health care providers, development partners (multilateral and bilateral agency representatives), civil society representatives (non-governmental organizations [NGOs], faith-based organizations [FBOs]), and technical specialists and programme managers. Survey techniques should be designed to capture the range of experiences and opinions stemming from the in-country process. Survey and interview instruments should be pilot-tested, with the results of piloting reviewed by the Steering Committee. Face-to-face interviews should be supplemented by telephone interviews or email surveys as needed to obtain relevant information Additional data and information may need to be collected at country level on total and government expenditures on health; donor contributions to health systems strengthening, including GAVI; total GAVI contributions to countries; immunization coverage data based on JRF and/or MICS/DHS data (supplemented by country-level information where appropriate). Country-level work will need to be complemented by review and analysis of secondary information specific to countries, including: HSS grant information; country profiles and reviews; and additional data (World Development Indicators and National Health Accounts data), among others.

GAVI Alliance

RFP-0006-08 Page 9 of 31

The Independent Evaluation of GAVI HSS should require in-depth country-level reviews and assessments in at least five (5) countries. In-depth country work could possibly be paired with a lighter assessment in additional countries.

3. Analytical work Outputs should contribute to the creation of a database of values for indicators for GAVI HSS countries, including the 3 required indicators and the three additional output indicators; demographic and other health information; HMN indicators; and other relevant indicators (GNI/capita, etc), country-level disbursement rates, etc.. Simple analysis of means/medians by indicator; changes in indicators over time for the sample of countries as a whole, by region, and by funding duration should be conducted. Based on the information collected, the successful bidder should work with the relevant oversight committee to determine whether any further analytical work, could be conducted to show associations between GAVI HSS Investments at country level and changes in indicators or health systems outputs.

4. Relationship between the HSS Evaluation and the Tracking Study As discussed in the Background Section of this RFP, the GAVI HSS Tracking Study will provide detailed information on design and implementation issues related to GAVI HSS. The Tracking Study will include in-depth country work culminating in six country case studies in Ethiopia, DR Congo, Viet Nam, Nepal, Kyrgyz Republic, and Zambia. This would will not be completed before the HSS Evaluation is commissioned but will be a concurrent exercise. However, the findings of the Tracking Study will be a substantial source of information for the Evaluation Team, and the GAVI Secretariat will facilitate sharing and discussion of preliminary findings and reports as needed. The 2009 Evaluation of the GAVI HSS Window should incorporate the findings of the Tracking Study.

VI. Management
&
Oversight
:


3) Project
Management
 The GAVI HSS evaluation will be outsourced in its entirety to consultants. The GAVI Secretariat will be the focal point for the consultants and provide the day to day operational support.

4) Oversight


All efforts will be made to ensure that this is an independent evaluation of the GAVI HSS window. The oversight of this evaluation will be defined by the GAVI new governance structure in early 2009 and communicated to the winning bidder.

The Contractor team will receive support and technical oversight in relation to identifying stakeholders to be interviewed, refinement of the question posed in Annex 3, recommendations on methods, review and comments on deliverables and timetable for completing work.

GAVI Alliance

RFP-0006-08 Page 10 of 31

VII. Qualifications:
 The GAVI Alliance values proposals that include significant involvement of GAVI Alliance partners. Consultants or bidders should design the effort as a collaboration among the partners that leverages existing knowledge as much as possible. Knowledge of the GAVI partner environment and relevant global health stakeholders will be essential. It is also essential that the successful bidder acknowledges ways in which this study will add capacity to and link with key national and regional institutions – the bidder must therefore demonstrate either previous experience with linking with national or regional institutes, or methods of how to do this. The qualified recipient team should have:

a) Clear understanding of the design and governance of health systems, health systems monitoring in low-income countries, and understanding of new initiatives such as IHP+.

b) Demonstrated expertise and extensive experience in evaluation of health systems, both quantitative and qualitative methods, including knowledge of methods and approaches for tracking studies.

c) Demonstrated expertise in conducting program evaluations and assessments of GHPs. d) )Partnership with institutions in developing countries. e) Expertise in conducting surveys in both Anglophone and Francophone developing countries with a

wide range of stakeholders, and with the management of multi-country evaluation activities and larger networks.

f) Proven capability to establish country networks on health systems themes, and to use networking as a way of identifying and solving health systems issues.

g) Demonstrated experience in capacity building at national and regional levels. h) The work should be conducted primarily by a mix of team members from national and regional

organizations and institutions, complemented by international expertise, as needed. i) Proven ability to prepare timely and succinct documentation and reports in English, accessible to a

wide range of stakeholders (technical and non-technical).

VIII. Project
Deliverables
 The deliverables must meet the five objectives stated in section III and provide a specific response for each point in Section IV. The deliverables: 1. Inception Report- This document should further refine methods, activities, deliverables, and timeline due on March 1, 2009. The Inception Report should contain the list of countries to be selected for in-depth work and for other types of assessments. 2. Draft report (we expect the draft report in two parts)

a. Part 1, in relation to components 1 and 2 of the scope of work due on 27 July, 2009 b. Part 2, in relation to component 3 of the scope of the work due on 15 August 2009

3. Final report ( in two parts)

a. Part 1 in relation to components 1 and 2 of the scope of work due on 30 September , 2009 b. Part 2, in relation to components 3 of the scope of work due on 15 October 2009

Required draft and final reports contents:

GAVI Alliance

RFP-0006-08 Page 11 of 31

(1) Part 1 in relation to components 1 and 2 of the scope of work (a) Results as per the Scope of Work (Section IV above), highlighting major successes,

trends, and challenges.

(b) Recommendations to the GAVI Board on a) whether the HSS window should be maintained, for how long, and in what capacity; b) how HSS support at country, regional, and global levels should be strengthened?

(c) Assessment of whether current conceptual frameworks linking GAVI HSS financing

to changes in immunization outputs/outcomes are sufficiently robust to demonstrate correlation between GAVI HSS support and changes in immunization coverage and U5 mortality.

(d) Database of indicators:

(i) A table showing the trends in the three required outcome indicators over the life of

GAVI HSS for countries and regions (DTP3, % district > 80%; U5 mortality). (ii) A table showing the trends in the optional outcome indicators for only the selected

in-depth study countries, over the life of GAVI HSS for countries and regions. (iii) Analysis of trends from these two tables in terms of provision of HSS funding and

changes over time in immunization and other outcome indicators.

(2) Part 2, in relation to component 3 of the scope of work (a) Proposed TOR for the 2012 Evaluation, including data and information that must be

collected and analyzed, and systems that need to be put in place to support the evaluation.

(b) Proposed specific recommendations to strengthen the conceptual framework for the 2012 evaluation, indicating what elements and additional research would be needed to better assess the impact of GAVI HSS funding

(c) Define areas for further specification and refinement of the evaluation questions and data collection activities to be conducted in 2012.

(d) Identify areas for further study that specifically would improve the quality of the 2012 Evaluation.

IX. Pricing
and
Cost
Information:
 Bidders are expected to budget sufficient resources to accomplish the objectives, but to do so in a cost efficient manner. Detailed budget justification notes should accompany the budget

1) Price
for
Delivery
of
Each
Main
Task
 The pricing submitted for this Request for Proposal shall be itemized and tied to the successful completion of each main task indicated in the project work plan (for invoicing purposes). The total price for completing each of the main tasks shall also be provided in summary form.

2) Costs
for
Reimbursements


GAVI Alliance

RFP-0006-08 Page 12 of 31

Please detail the specific items which will need to be reimbursed for during the execution of the proposed project plan. The total cost for reimbursable items are to be estimated and listed in detail separately for evaluation purposes.

3) Total
Cost
of
Proposal
 The total price for successfully completing each main task plus the total reimbursable costs for the project will be considered the total cost of the proposal submitted.

X. Timeline:
 Note: All “Event Dates” shall be executed by 5pm EST time.

RFP Life Cycle Management Schedule

Event Type Event Date Submission of RFP to Prospective Firms November 21, 2008 Receipt Date of Proposals January 5, 2009 Selection of Winning Proposal January 31, 2009 Award Contract to Selected Firm February 15 , 2009 Begin work on Technical support March 1, 2009 Inception Report Due March 30, 2009 Submission of the Draft report (part 1) July 27, 2009

Submission of the Draft report (part 2) August 15, 2009

Submission of the Final Report (Part 1) September 30, 2009

Submission of the Final Report (Part 2) October 15, 2009

XI. Contact
Information:
 All questions should be sent in writing via email directly to Abdallah Bchir CC: to Rashard Dyess-Lane. In order to keep the RFP competition fair, questions on the substance of the RFP will only be answered in a public document released on or around 15 December 2008. Please do not contact other GAVI staff to discuss the RFP.

The GAVI RFP Contact Information

Question Type Contact Person Contact Role/Title Contact Information

Contractual Rashard Dyess-Lane Procurement 1776 Eye Street, NW

GAVI Alliance

RFP-0006-08 Page 13 of 31

RFP & Contract Terms & Conditions, Proposal Format, etc.

Manager Suite 600 Washington DC 20006 USA Phone: +1 202-478-7739 Fax: +1 202-318-2647 Email: rlane@gavialliance.org

Technical

RFP Deliverable Specifications & Requirements

Abdallah Bchir Senior Program Officer (Evaluation)

Abdallah
Bchir
GAVI
2,
Chemin
des
Mines
1211,
Geneva
2
Switzerland
 Phone: +41 22 909 6542 Fax: +41 22 909 6550 Email: abchir@gavialliance.org

XII. Evaluation
Criteria:
 The technical component of the proposal will be evaluated by an evaluation committee, which will include 2 members from the GAVI HSS Task Team, and 3 independent international health systems and evaluation experts. The Technical Proposal will be scored and ranked according to the criteria below.

Technical factors % of total score Demonstrated understanding of health systems, health systems monitoring, and techniques and approaches for evaluating the use and outcome of additional resources for health systems strengthening. Criteria for country selection, prioritization of illustrative questions, and relationship between the two. Quantitative and qualitative methods proposed for undertaking both the in-depth country reviews, review of support processes, and analysis of outputs &outcomes if possible. This will include questions to be addressed and methods to collect and analyze country information. Timeline of activities along with the required deliverables, including starting and ending dates for completion of all work.

60%

Ability of the bidder to carry out scope of work (based on qualifications of the team, including CVs of key experts). Demonstrated expertise of the contractor in analytical methods and country-based survey research (qualitative and quantitative).

40%

GAVI Alliance

RFP-0006-08 Page 14 of 31

Partnership with institutions in developing countries Once a short list has been created for the technical proposals, the cost proposals will be evaluated and ranked in terms of value for money, budgeting process and willingness to accept standard terms and conditions.

XIII. Proposal
Requirements


Any award to be made pursuant to this request will be based upon the proposal with appropriate consideration given to all criteria stipulated herein. In addition to the specific evaluation criteria referenced above, evaluation of proposals will also be based upon your responsiveness to the request and the total price quoted for all items covered hereunder. The following elements will be the primary considerations in evaluating all submitted proposals and in the selection of a contractor or contractors:

Executive Summary This section should present a high-level synopsis of your responses to the proposal. The Executive Summary should be a brief overview of the engagement, and should identify the main features and benefits of the proposed work, as well as, a brief statement outlining the Proposer’s understanding of the tasks and requirements of the work to be conducted. Scope, Approach, and Methodology This section should include a) description of the methods and approaches to be used for both in-depth and other types of analysis of GAVI HSS at country level, including discussion of the criteria for country selection; the specific questions to be addressed in each country; and, the methods and approaches to be used in the evaluation b) development of the questionnaire to be used during interviews, and a description of how interview biases will be minimized and responses categorized to provide meaningful cross-country comparisons c) proposed approach for conducting the assessment of all countries approved for GAVI HSS funding d) proposed timeline of activities along with the required deliverables, including starting and ending dates for completion of all work. e) description of how the expertise and capacity of local and regional institutions will be utilized in the case studies and in the project overall. . Project Management Approach Include the method and approach used to manage the overall project and client correspondence. Briefly describe how the engagement proceeds from beginning to end. A detailed description of in-house quality assurance mechanisms for enduring proper monitoring of work progress and for ensuring the quality of deliverables should also be included. References Attach three (3) current corporate references, including company name, contact name, title, address, telephone number, and client relationship synopsis. Please also demonstrate your partnership(s) with research institutions in GAVI eligible countries.

GAVI Alliance

RFP-0006-08 Page 15 of 31

Project Team Staffing Include biographies and relevant experience of key staff and management personnel. List the personnel who would work on this project along with their qualifications and relevant experience. Details of the roles and responsibilities of various team members and procedures to ensure team leadership continuity should also be included. Finally, affirm that no employees working on the engagement have ever been convicted of a felony. Company Overview Include official registered name (Corporate, D.B.A., Partnership, etc.), Dun & Bradstreet Number, Primary and secondary SIC numbers, address, main telephone number, toll-free numbers, and facsimile numbers. Key contact name, title, address (if different from above address), direct telephone and fax numbers. Person authorized to contractually bind the organization for any proposal against this RFP. Brief history, including year established and number of years your company has been offering services of this type. Project Work Plan and Time-Line Please provide a project work plan broken down into phases which clearly identify the conceptual project methodology that shall be used. Each phase of the project must provide a detailed time line of the tasks to be completed and gave staff resources assigned to each task within the phase. Detailed Cost Proposal See Section 10 Above

XIV. Required
Proposal
Format:
 Guidelines for Proposal Submission Bidders must submit one (1) electronic proposal via email to Abdallah Bchir with CC: to Rashard Dyess-Lane. Bidders must submit eight (8) hard copy proposals in printed, bound format via postal mail. Technical and cost proposals are to be bound separately. One (1) hard copy of the proposal must be submitted via postal mail to: Rashard Dyess-Lane Procurement GAVI Alliance 1776 Eye Street, NW Washington, DC 20006 USA Three (3) hard copies of the proposal response must be submitted via postal mail to: Abdallah bchir

GAVI Alliance

RFP-0006-08 Page 16 of 31

GAVI 2, Chemin des Mines 1211, Geneva 2 Switzerland **Supplemental proposals may be submitted via facsimile, hard disk files or email files which contain digital signatures. However, such proposals shall not constitute a substitute for the hard copies of proposals which must be submitted to be considered official submissions. For postal mail submissions, the envelope or container containing a bid should be clearly marked on the outside with (1) the official RFP number and (2) of the official target date and time. Individual bids for different RFP’s should not be combined or placed in the same envelope as other RFPs. An Independent Review Committee (IRC) composed of broad expertise in health systems; epidemiology and evaluation will be formed to evaluate the proposals. The IRC will use the criteria outlined in this RFP in their evaluation. Award of the contract resulting from this request will be based upon the most responsive contractor(s) or whose offer will be the most advantageous to the GAVI in terms of cost, functionality and other factors as specified elsewhere in this request. Your proposal should be submitted as set forth herein. Please confine its submission to those matters sufficient to define your proposal, and to provide an adequate basis for the evaluation of your proposal. Your proposal in response to this request will be incorporated into the final agreement between the GAVI and the selected Contractor(s). The submitted proposals are suggested to include each of the following sections:

• Technical response stating in detail how the applicant intends to meet the objectives described in this RFP. The technical response should detail activities as well as the performance requirements against which an applicant would be measured through 2011, the end of the initial contract term. The technical response should also detail activities and performance requirements through 2015, the period for which the contract could potentially be renewed.

• Financial response setting out a detailed budget and justifications for the budget. Written Confirmation of Intent Each consultant shall transmit a written confirmation of intent by 5pm EST on 12 December 2008. Please transmit your intent to participate using the language attached hereto as Annex 5. Acceptable means of transmission include facsimile, mail or computer file with digital signature. All written confirmations of intent to participate shall be delivered to:

GAVI Procurement 1776 Eye St NW Suite 600 Washington DC 20006 USA Fax: (202) 318-2647

GAVI Alliance

RFP-0006-08 Page 17 of 31

Email: rlane@gavialliance.org Please fill in your company’s name and include the text on the following page on your company’s letterhead. The GAVI Fund will countersign and return a copy to you for your records:

GAVI Alliance

RFP-0006-08 Page 18 of 31

Annex 1: More detailed information about GAVI HSS The objective of GAVI HSS is to achieve and sustain increased immunization coverage, through strengthening the capacity of the health system to provide immunization and other health services (with a focus on child and maternal health). Countries are encouraged to use GAVI HSS funding to target the “bottlenecks” or barriers in the health system that impede progress in improving the provision of and demand for immunization and other child and maternal health services. GAVI HSS should address health system barriers that are known to impede the demand for and delivery of immunization and other child and maternal health services, particularly at district level and below. The nature and degree of system-level barriers will vary both within and between countries, however GAVI recommends that countries consider three main areas for GAVI HSS support, all focusing on strengthening health systems functions at the district level and below. The three areas are based on assessments of health system barriers in GAVI-eligible countries. The three main areas for GAVI HSS support are:

1) health workforce mobilization, distribution and motivation targeted at those engaged in immunization and other health services at the district level and below

2) organization and management of health services at the district level and below (including financial

management)

3) supply, distribution and maintenance systems for drugs, equipment and infrastructure for primary health care

These areas are not exc lus iv e . GAVI HSS can target one of these areas, all three of these areas, or other areas altogether that impede the delivery of immunization and other child and maternal health services, as long as the application shows how the GAVI HSS activities will improve and / or help sustain immunization coverage in the country. GAVI HSS support is available for the length of the National Health Sector Plan (or country equivalent) or less - typically three to five years8. Countries can re-apply for GAVI HSS support as often as a new National Health Sector Plan or Strategic Policy or cMYP is developed9. If countries are mid-way through a planning cycle, GAVI HSS support can be provided to cover until the end of the current cycle. Another application will need to be submitted to cover (up to) the next full cycle of the National Health Sector Plan (or country equivalent). GAVI HSS support is not appropriate for countries with

8 In cases where there is a difference between the two, the application should be aligned with the timeframe of the broader health sector plan. 9 The GAVI Board has approved the funds for all countries to receive GAVI HSS support up to 2010, with a possible extension to 2015. The extension will depend on the outcome of an evaluation due to take place in 2009.

GAVI Alliance

RFP-0006-08 Page 19 of 31

less than a year before the end of the current planning cycle, but should be planned for the start of the next Health Sector Strategic Policy or cMYP. Monitoring should be able to demonstrate outputs and outcomes / impact of the GAVI HSS investment through the measurement of carefully chosen prioritized indicators that will be measured accurately and used on a regular basis to guide programme direction. Priority choice should be given to SMART10 indicators (with baseline data) that the country already measures and uses as not to place any greater burden on the existing Health Information System. Both national and sub national levels need to monitor and use data on a constant basis to better inform decision makers at all levels. The selection of and use of indicators should benefit peripheral levels, as outlined in the WHO / UNICEF Reaching Every District (RED) strategy. If deemed a priority, GAVI HSS funds may be used to strengthen the Health Information System. The three overall impact / outcome indicators which will be used to evaluate the GAVI HSS investment are:

1. National DTP 3 coverage 2. Numbers / % districts11 achieving ≥90% DTP3 coverage 3. Under five mortality rate

These three impact / outcome indicators must be included in all applications. Up to three more impact / outcome indicators may be selected and could include other co-coverage indicators. Examples of such indicators may be seen in section 6 of the application form. Up to six output indicators may be included but at least one output indicator should be included for each objective and its related activities. These indicators need to be chosen carefully to ensure that baseline data are available, milestones and targets are achievable as they need to be reported in the annual progress report. Any of these indicators may be further disaggregated (if the country feels this would be useful) to include information on geographic / gender / urban rural or private / public differences, which could help further guide programme implementation. Although not a mandatory requirement for an HSS proposal, countries are aware that HSS proposals and the HSS investment evaluation will be monitored in the context of indicators for Aid Effectiveness12 outlined by the OECD Development Assistance Committee (DAC) and detailed in the Paris declaration on AID effectiveness, March 2005. During the timeframe of the proposal, it may be necessary for countries to adjust activities according to indicators and feedback from various sources. Any changes to activities and reasons for these changes should be highlighted in Annual Progress reports, which will be reviewed by the Monitoring IRC.

10 Specific, Measurable, Achievable, Realistic and Time-bound 11 Or equivalent administrative unit 12 12 indicators broadly classified as ownership, alignment, harmonisation, managing for results and mutual accountability,

GAVI Alliance

RFP-0006-08 Page 20 of 31

Annex 2: Estimated Length of Time with GAVI HSS Resources at Country Level Annex 2 illustrates the length of time that countries will have had GAVI HSS financial assistance at the estimated time of the start of the Evaluation (January 2009). Three countries will have had assistance for 20 months (Ethiopia, Cambodia, and Burundi). An additional eight countries will have had assistance for 14 months (Kyrgyz Republic, Georgia, Liberia, Viet Nam, Afghanistan, Rwanda, Yemen, and Zambia. Five countries will have had assistance for between 8-10 months (Congo DR, CAR, Ghana, Madagascar, and Nicaragua. Kenya, Sudan North, and Bhutan will have had resources for 6 months. Round

Date country confirmed receipt of

funds (from APR where available)

Time (months) at the start of the

Evaluation (01//09)

Amount Received As of 9/08

Round 1

Burundi 09/04/07 20 months $2,704,000

Cambodia 11/04/07 20 months $1,850,000

Ethiopia 13/04/07 20 months $68,840,803

Korea DPR Not sent 0 months $0

Kyrgyz Rep 07/09/07 15 months $679,500

Round 2

Congo DR 08/02/08 10 months $41,665,500

Georgia 13/08/07 16 months $188,500

Liberia 27/07/07 17 months $2,045,000

Vietnam 08/08/07 16 months $6,959,500

Round 3

Afghanistan 29/10/07 14 months $11,295,000

Cameroun 06/11/07 13 months $3,770,000

Kenya 06/06/08 6 months $5,831,000

Pakistan Not sent 0 months $0

Rwanda 29/10/07 14 months $2,174,000

Yemen 29/10/07 14 months $2,574,000

Zambia 12/10/07 14 months $2,917,500

Round 4

Bhutan 03/06/08 6 months $37,500

Central African Republic 29/04/08 8 months $1,893,000

Ghana 30/04/08 8 months $1,035,500

Honduras 12/05/08 7 months $1,094,000

GAVI Alliance

RFP-0006-08 Page 21 of 31

Madagascar 30/04/08 8 months $811,000

Malawi Unknown $3,641,000

Nepal 02/05/08 7 months $6,166,500

Nicaragua 30/04/08 8 months $343,500

Nigeria Unknown $22,098,500

Sierre Leone Unknown $1,154,000

Sri Lanka 02/05/08 7 months $887,500

Sudan North 06/06/08 6 months $3,064,000

Uganda Not sent

Round 5 Armenia Not sent $94,500 Bolivia Not sent $697,000 Burkina Faso Not sent $3,074,000 Cambodia Not sent $337,500 Cote d'Ivoire Not sent $1,790,000 Guinea Bissau Not sent $338,500 Indonesia Not sent $7,961,000 Mali Not sent $1,373,000 Myanmar Not sent $3,649,000 Tajikistan Not sent $282,000 Tchad Not sent $707,000

GAVI Alliance

RFP-0006-08 Page 22 of 31

Annex 3: Illustrative Questions to be Addressed in the Evaluation 1. Country level 1.1 Design of GAVI HSS

a) Do the activities being designed for GAVI HSS appear to address the main bottlenecks of achieving higher immunization coverage or are they addressing bottlenecks not specific to achieving immunization outcomes? The HSS Guidelines propose three suggested areas for support- are countries largely following this guidance—is the guidance relevant for addressing main bottlenecks, as identified in country proposals?

b) How well-integrated, harmonized, and aligned was programming of HSS resources into the national health plan, and to what extent was HSS programming multisectoral in nature? Across countries, has GAVI HSS been programmed to fill gaps in the national health sector strategy, finance innovative pilots for overcoming bottlenecks, fund specific programs?

c) To what extent is GAVI HSS funding linked and additional to GFATM, IHP+, World Bank, other GAVI support (CSO, ISS), and other health systems initiatives? Are there any potential redundancies or gaps that GAVI HSS could be directed towards?

d) How does the GAVI HSS funding request compare to health systems support from other donors and the government itself? What are the perceived advantages of GAVI HSS funding compared to other sources of support for the health sector? What are the perceived disadvantages?

e) What has been the country’s experience with the GAVI HSS application and IRC review processes? f) What technical assistance and support was used in the design and programming process?

1.2 Implementation of GAVI HSS

a) What activities have so far been implemented at country level and how do these differ from what was proposed in the HSS application/approved by the IRC? What factors have contributed to these differences, and what processes were used to plan and approve changes?

b) What are the main challenges for the implementation of GAVI HSS? c) What is the average length of time that countries have implemented GAVI HSS (used GAVI HSS

resources for proposed activities)? d) To what extent have partners been involved in implementation of GAVI HSS? How does this

compare with involvement in design, and what are constraints to partner involvement? e) National budgeting: Is GAVI HSS on-budget? Is GAVI HSS funding in a pooled account (with what

other resources) or separate account? Is it part of a forward planning and budgeting process, such as an MTEF?

f) Financial management: In addition to GAVI APR requirements, what are the national requirements and process for monitoring and reporting on the use of GAVI HSS funds? What is the financial channel for GAVI HSS funds and how does it relate to other financing channels for health systems? How is disbursement of GAVI HSS resources monitored at country level?

g) Procurement: How have GAVI HSS funds been used for procurement of equipment, vehicles, construction of buildings, and how well has the process followed national guidelines?

h) What technical assistance will be used in the implementation and monitoring process?

GAVI Alliance

RFP-0006-08 Page 23 of 31

1.3 Monitoring of GAVI HSS a) What is the relevance of country-specific M&E frameworks to the proposed objectives and activities,

and to what extent have they been implemented? b) To what extent is the monitoring system for GAVI HSS harmonized and aligned with national

processes and common frameworks, and to what extent are HMN indicators being used? c) What are countries’ perceptions of HSS reporting requirements, and what do countries suggest to

improve HSS reporting? To what extent are they viewed as separate processes? Have they contributed to strengthening MOH monitoring, HMIS, and reporting?

d) What specific mechanisms are used to monitor progress against agreed upon HSS indicators, and how effective are they? Who is responsible for acting upon performance problems at each level? How is the monitoring system being used to improve immunization performance?

e) What is the country experience with completing the APR and fulfilling requirements of the APR? f) For all countries approved for HSS funding, analyze and finalize the database of the HSS indicators

included in the GAVI HSS proposals, with baseline values and annual milestones to measure progress. Highlight any gaps or inconsistencies in baseline values and supplement missing information with data obtained through either country visits or secondary data analysis. As part of consistency checking, compare the baseline values with those reported on in the APRs. [NB: The GAVI Secretariat will be able to provide the initial database of indicators to the evaluation team.]

1.4 Governance of GAVI HSS

a) Describe the range of governance arrangements in countries for GAVI HSS—to what extent are government ministries and departments; private sector, SCOs, and academia involved in implementation and management of GAVI HSS? Are there any governance arrangements that appear to be more successful than others?

b) To what extent have GAVI HSS resources been integrated into national planning, implementation, procurement, financial management and reporting, and budgeting processes, i.e., Joint Reviews, etc.?

c) What have been the roles, responsibilities, and value-added of partners and stakeholders represented in national Health Sector Coordination Committees (HSCCs) and the ICCs in the design and implementation of GAVI HSS? Why were some partners not formally involved, and what can be done to strengthen their collaboration? [NB: The evaluation team can draw upon earlier work conducted in this area by the Tracking Study and the WHO/UNICEF proposal review].

1.5 Overall

a) What is the likely sustainability of the activities funded by GAVI HSS, and what do stakeholders perceive as the main risks and challenges to sustainability?

b) Have GAVI HSS resources been targeted in ways to contribute to improved access to primary health services, greater equity in immunization coverage, better quality and efficiency of service delivery?

c) What have been the unanticipated consequences of GAVI HSS on donor coordination and participation, district/operational level functioning, beneficiary/community level perspectives?

d) Does the HSS work catalyse more harmonization of partners’ in-country efforts, and does it promote more alignment of external support with the national health strategy?

e) What are the in-country overall impressions of GAVI HSS?

GAVI Alliance

RFP-0006-08 Page 24 of 31

2. Global and Regional Level Processes The evaluation of global and regional level processes should be conducted through structured interviews with relevant stakeholders, such as the regional focal persons for WHO and UNICEF on GAVI HSS; members and co-chairs of the GAVI HSS Task team (past and present); country cluster officers of the GAVI Secretariat; GAVI Secretariat staff involved in GAVI HSS (including monitoring and communications); members of the HSS and monitoring IRCs (past and present); WHO staff involved in the pre-review process of GAVI applications; and selected individuals from GAVI Alliance partners representing relevant governance structures (i.e., Working Group members, PPC members, Executive Committee members, and/or Board members, and GAVI Secretariat and GAVI Fund staff and management). The processes to be considered in the Evaluation of the GAVI HSS Window are the following: Regional Working Groups (RWGs), the HSS Task Team, GAVI Secretariat country visits, support and communications; the HSS Independent Review Committee (IRC) and Monitoring IRC; pre-review processes; disbursement processes to countries; and the Guidelines, Application and Updates for HSS: 2.1 According to in-country sources, what support has been received from regional and global levels and

from which organization? [NB: Some of this information may be obtained from the Technical Support Assessment to be furnished by the GAVI Secretariat.]

2.2 What are the main accomplishments of global and regional support mechanisms, and are these

mechanisms largely fulfilling their roles and objectives? 2.3 What are the potential gaps in support and limitations in current support mechanisms? 2.4 What are the main areas for improvement for each of these processes? Should they be continued in their

current form and skill set to meet the challenges in the coming years? 2.5 How well has the GAVI Secretariat supported HSS in the areas of communications to countries,

disbursement of resources, development of policies and procedures, monitoring and technical capacity. 2.6 How has the time period from proposal submission to receipt of funding changed over time? What factors facilitate this process and what factors delay the process? How can the process be improved? [NB: This information will be furnished by the GAVI Secretariat to the evaluation team]. What has been the role of IFFIm resources in disbursements and what types of activities are IFFIm resources funding? 3. Outputs and Outcomes Realizing that few countries receiving GAVI HSS will have had resources for more than two years, it is still important to assess and document any changes in outputs that have been obtained during this period. 3.1 Prepare a spreadsheet and graphics (tables/charts) showing changes in the three required outcome indicators from 2005 to the present by country and WHO region (DTP3, % district > 80%; U5 mortality). The expectation is that few countries will have had DHS or MICS surveys since inception of GAVI HSS support that could possibly be used as data sources on changes in U5 mortality. The evaluation team should develop an information source for the future evaluation on when these surveys may be completed in GAVI HSS countries to serve as information sources on this indicator.

GAVI Alliance

RFP-0006-08 Page 25 of 31

3.2 Prepare a spreadsheet and graphics (tables/charts) table showing changes in the optional outcome indicators for the selected study countries over the life of GAVI HSS for countries and regions. 3.3 What proportion of GHE does GAVI HSS resources represent based upon the approved full amount of potential HSS funding? Do large HSS grants make sense and under what criteria?

1.4 What is performance of GAVI HSS countries relative to key Health Metrics Network indicators for health systems? Develop a database on HSS countries and HMN indicators for the period 2005-present by country and by WHO region. HMN indicators covering financing of health services; financial protection; human resources; health information and management systems; governance; service delivery; and equity. Coverage information will already be analyzed in 3.1 above.

4. Preparing for the 2012 Evaluation 4.1 What are the main strengths of GAVI HSS processes and mechanisms at country, regional, and global

levels? 4.2 What areas need further strengthening for GAVI HSS at country, regional, and global levels, to optimize

the impact of HSS funding? 4.3 What should be the main aims and scope of an evaluation of GAVI HSS in 2012? 4.4 What additional frameworks need to be put in place at country level in preparation for the 2012

evaluation? 4.5 What types of process indicators might be recommended to countries to monitor in the future, and how

can these be monitored within country systems or with a strengthened APR?

GAVI Alliance

RFP-0006-08 Page 26 of 31

Annex 4: Information to be provided to the evaluation team

Baseline data collection

To be prepared by the GAVI Secretariat, to ensure sufficient baseline data is available to conduct an accurate, appropriately focused and timely evaluation.

• All final versions of GAVI HSS guidelines and application forms, including HSS Updates. • A list of the actual timings and amounts of GAVI HSS disbursements to each of the study

countries, through 1 November 2008. • Full documentation (Decision Letters and communications on clarifications, conditions, and

other recommendations) on HSS awards to countries. • Reports and recommendations of the HSS IRC. • Pre-review reports and materials. • HSS Task Team meeting minutes and communications (during which design issues were

discussed). • Reports and recommendations of the Monitoring IRC. • Regional working group meeting minutes. • Communications to GAVI Secretariat regarding requests for technical support and assistance.All

reports describing studies, missions or other analytic work, relevant to GAVI HSS processes and efforts for the country studies.

• Reports and Action Plans on regional meetings, such as Sharm-El-Sheikh • A table showing the disbursement rate for GAVI HSS to countries, specifying the time between

initial approval and first disbursement, and the exact time in days between APR reception and subsequent disbursements, for each country.

• List of HSS indicators put forth in the country applications compared with those in the Annual Progress Reports.

• Based on received APRs, a list of any differences between proposed and actual implementation, either in types and number of activities, based on the approved version of the final GAVI HSS proposal (i.e. incorporating all clarifications and conditions required).

• Summary and individual IRC reports for each round of GAVI HSS funding, including preliminary or final reports from the October 2008 HSS and M&E IRC meetings.

• Document listing the objectives, functions, operations and staffing of global and regional processes.

GAVI Alliance

RFP-0006-08 Page 27 of 31

Various documents: analysis, decisions, guidelines

a) 2005 Business Case for HSS (Investment Case) b) Copies of all Board Decisions and Guidances on GAVI HSS c) The HSS Workplan (SG2) for 2008 d) The HSS workplan for 2009-2010, once approved by GAVI Board e) 2007-10 GAVI Roadmap f) WHO/UNICEF/UNFPA: The 49 country HSS proposal analysis g) World Bank assessment of monitoring in GAVI HSS proposals h) World Bank analysis of GAVI HSS proposal budgets i) Update to countries on GAVI Alliance HSS and CSO support – July 2008 j) Sharm el Sheikh Action Points for HSS from the 15-17 July 2008 Third Face-to-Face Meeting of

WHO, UNICEF and World Bank HSS Focal Points from Regions and Headquarters; Supporting countries to strengthen health systems for effective delivery of primary health care

k) HMN reference materials l) Final Axios Report on Consultancy Services for Conducting a Monitoring and Availability Study for

GAVI’s Health System Support to Countries

GAVI Alliance

RFP-0006-08 Page 28 of 31

Selected References

1. Ten methodological lessons from the multi-country evaluation of integrated Management of Childhood

Illness; Bryce J, Victora CG; Health Policy Plan. 2005 Dec;20 Suppl 1:i94-i105; Universidade Federal de Pelotas, CP Pelotas RS 96001, Brazil

2. Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact; JP Habicht , CG Victora , and JP Vaughan; Int. J. Epidemiol. 28: 10-18.

3. Evaluating effectiveness of complex interventions aimed at reducing maternal mortality in developing countries, Louise Ross , Padam Simkhada , and W. Cairns S. Smith; Journal of Public Health 27: 331-33, DOI 10.1093/pubmed/fdi058.

4. Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up, Kara Hanson, M. Kent Ranson, Valeria Oliveira-Cruz, Anne Mills, Journal of International Development, 15:1, 1-14, 2003 http://dx.doi.org/10.1002/jid.963

5. Monitoring Health Systems Strengthening Technical Working Group document on HMN indicators. July 2007 (or more recent documentation).

GAVI Alliance

RFP-0006-08 Page 29 of 31

Annex 5 — Written Confirmation of Intent to Participate

Intent
to
Participate

To:


Rashard Dyess-Lane

Email:
 rlane@gavialliance.org


From:
 ______________________________

Company
Name:

 ______________________________

Mailing
Address:
 ______________________________


 ______________________________


 ______________________________


 ______________________________


 ______________________________

Contact
Name:
 ______________________________

Title
 ______________________________

Telephone:
 ______________________________

Email:
 ______________________________





 Status


We plan to submit a proposal in response to GAVI Alliance RfP NAME and therefore insert your company name confirms and agrees to the following:

GAVI Alliance

RFP-0006-08 Page 30 of 31

(1) Confirmations. Insert your company name confirms that:

a. It is not currently under investigation for nor has been otherwise declared

ineligible to provide services to any GAVI Alliance member as a result of findings of fraudulent, corrupt, collusive or coercive practices.

b. It does not exploit child labour or otherwise violate human rights in the conduct of its business.

c. To the best of its knowledge, Insert your company name does not engage in any discrimination based on race, colour, religion, sex, marital status, national origin, age, disability or sexual orientation.

d. Insert your company name uses Its best efforts to be an environmentally friendly company, promote and apply fair-trade principles

(2) Confidentiality. Each party signing below will protect from unauthorized

disclosure any non-public written information, provided to it in connection with this proposal for the GAVI Alliance (“Confidential Information”). Neither party will disclose the other parties confidential Information to any third party without prior written consent, except to a GAVI Alliance evaluation panel, GAVI Alliance personnel and to advisors and other service providers under confidentiality obligations sufficient to ensure compliance with this paragraph. Each party will use the same degree of care to protect the other party’s Confidential Information that it uses to protect its own confidential information, which in no instance shall be less than a commercially reasonable amount of care.

(3) Dispute Resolution. Any dispute, controversy or claim arising out of or in connection with this Agreement, unless settled amicably, shall be settled by arbitration in accordance with the arbitration rules of the United Nations Commission of International Trade Law (UNCITRAL Arbitration Rules) presently in force. The appointing authority shall be the President of the Swiss Arbitration Association (ASA). The number of arbitrators shall be one, unless otherwise agreed by the parties. The arbitration proceedings shall take place in Geneva. The language of the arbitration shall be English. The Parties agree to be bound by any award made by the arbitrator(s). Each party shall bear its own costs. Company waives and releases any right to enjoin or otherwise interfere with the decision made by the GAVI Foundation to appoint the winning bidder to perform Services described in this request.

(4) RFP Award Appeals Process. Any Bidder replying to this RFP may file a protest of the winning Contract award solely on the grounds that: (a) the GAVI did not follow all material terms of the written procedures described in this RFP when awarding the winning Contract; or (b) a Bidder believes in good faith that the evaluation team made a material mistake when reviewing the Bidder’s written response to this RFP and thus miscalculated the evaluation criteria scoring. To

GAVI Alliance

RFP-0006-08 Page 31 of 31

protest a winning Contract award, the Bidder must file a written protest containing all details constituting the grounds for protest, with the GAVI. The GAVI’s standard time for protest receipt is 14 calendar days since the bidders were notified : Protests must be sent to the attention of the GAVI General Counsel and must be clearly labeled “Award Protest”. The General Counsel may use reasonable means, in his or her discretion, to discuss the protest with the RFP evaluation committee and will use good faith efforts to obtain an independent review of the protest by individuals not part of such evaluation committee. The General Counsel will then issue a written explanation and ruling on the protest within 10 calendar days after the protest is received. Such explanation and ruling will be final.

We do not plan to submit a proposal in response to GAVI Alliance RfP NAME. Acknowledged and Agreed: The GAVI Alliance Company : Name: Name: Title: Title: Signature: Signature: Date: Date: